Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Prime Medicine (PRME) Operating Margin (2024 - 2025)

Prime Medicine (PRME) has disclosed Operating Margin for 2 consecutive years, with 5800.48% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Operating Margin fell 377473.0% year-over-year to 5800.48%, compared with a TTM value of 4498.06% through Dec 2025, up 228930.0%, and an annual FY2025 reading of 4498.06%, up 228930.0% over the prior year.
  • Operating Margin was 5800.48% for Q4 2025 at Prime Medicine, down from 4405.96% in the prior quarter.
  • Across five years, Operating Margin topped out at 2025.74% in Q4 2024 and bottomed at 25948.33% in Q3 2024.